These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

134 related articles for article (PubMed ID: 3530623)

  • 41. [The therapeutic effectiveness of chestnut extract].
    Hitzenberger G
    Wien Med Wochenschr; 1989 Sep; 139(17):385-9. PubMed ID: 2686181
    [TBL] [Abstract][Full Text] [Related]  

  • 42. [Trial use of aescine by drug dielectrolysis--apropos of 80 cases].
    Guillemin R; Estibal H; Bonelli AJ
    Electrodiagn Ther; 1977; 14(2):51-4. PubMed ID: 902632
    [No Abstract]   [Full Text] [Related]  

  • 43. [Horse chestnut seed extract--an effective therapy principle in general practice. Drug therapy of chronic venous insufficiency].
    Greeske K; Pohlmann BK
    Fortschr Med; 1996 May; 114(15):196-200. PubMed ID: 8767939
    [TBL] [Abstract][Full Text] [Related]  

  • 44. [Activity of the combination of escin, heparin sodium and diethylamine-salicylate as compared with the activity of the single components in minor traumatology].
    Dettoni A; Olivero C; Sibelli P
    G Clin Med; 1982 Apr; 63(4):279-83. PubMed ID: 7128983
    [No Abstract]   [Full Text] [Related]  

  • 45. [Therapeutic effect of a combination of bufenine and beta-escine as an oral delayed-action drug in obliterating arterial diseases of the lower limbs].
    Petruzzellis V; Scardigno A; Coviello C
    Minerva Med; 1982 Feb; 73(5):181-6. PubMed ID: 7038552
    [TBL] [Abstract][Full Text] [Related]  

  • 46. [The chronobiology and clinical efficacy of Daflon in the treatment of chronic venous insufficiency].
    Menyhelyi G; Acsády G; Hetényi A; Dubeaux D; Radó G
    Ter Arkh; 1997; 69(4):46-8. PubMed ID: 9213959
    [No Abstract]   [Full Text] [Related]  

  • 47. [Therapeutic effectiveness of flavonoids illustrated by daflon 500 mg].
    Hitzenberger G
    Wien Med Wochenschr; 1997; 147(18):409-12. PubMed ID: 9454438
    [TBL] [Abstract][Full Text] [Related]  

  • 48. [Toxicological studies on the administration by intravenous route of an escin-cyclonamine combination].
    Bamonte F; Craveri F; Crema A; De Pascale V
    Boll Chim Farm; 1976 Mar; 115(3):272-84. PubMed ID: 1275982
    [No Abstract]   [Full Text] [Related]  

  • 49. [Medical treatment of the anorectal varicose syndrome in gynecology and obstetrics].
    Tolino A
    Minerva Ginecol; 1979 Mar; 31(3):169-74. PubMed ID: 530456
    [No Abstract]   [Full Text] [Related]  

  • 50. [Venous diseases. Controlled study using an antivaricose preparation Bayro-Vas].
    Wolf W; Bayerl W; Nedjabat T
    Med Welt; 1975 Apr; 26(17):831-4. PubMed ID: 240994
    [No Abstract]   [Full Text] [Related]  

  • 51. [Varicose vein drugs--new attempts at objectivation of the effects of therapy].
    Marshall M
    Fortschr Med; 1984 Aug; 102(29-30):772-4. PubMed ID: 6500447
    [TBL] [Abstract][Full Text] [Related]  

  • 52. [External gel treatment of venous syndromes].
    Romeo S; Spinella G
    Clin Ter; 1978 Feb; 84(3):245-52. PubMed ID: 346297
    [No Abstract]   [Full Text] [Related]  

  • 53. [The principles of action and use of phlebotropic agents].
    Kharkevich DA
    Klin Med (Mosk); 2004; 82(11):4-10. PubMed ID: 15656390
    [No Abstract]   [Full Text] [Related]  

  • 54. [Value of using Reparil-gel in sports traumatology].
    Crielaard JM; Franchimont P
    Acta Belg Med Phys; 1986; 9(4):287-98. PubMed ID: 2954351
    [No Abstract]   [Full Text] [Related]  

  • 55. Clinical and capillaroscopic evaluation in the treatment of chronic venous insufficiency with Ruscus aculeatus, hesperidin methylchalcone and ascorbic acid in venous insufficiency treatment of ambulatory patients.
    Aguilar Peralta GR; Arévalo Gardoqui J; Llamas Macías FJ; Navarro Ceja VH; Mendoza Cisneros SA; Martínez Macías CG
    Int Angiol; 2007 Dec; 26(4):378-84. PubMed ID: 18091707
    [TBL] [Abstract][Full Text] [Related]  

  • 56. [Treatment by sandoven-f in patients with venous affections (author's transl)].
    Viviani E
    Schweiz Rundsch Med Prax; 1975 Oct; 64(41):1320-3. PubMed ID: 815900
    [No Abstract]   [Full Text] [Related]  

  • 57. [Drug therapy possibilities in non-complicated hemorrhoid disease].
    Ricchi E; Pezcoller C; Saviano M; Carrero A; Vincenzi G
    Clin Ter; 1986 Mar; 116(5):399-402. PubMed ID: 3709086
    [No Abstract]   [Full Text] [Related]  

  • 58. [Therapeutic effects of Reparil. Clinical experimental studies and therapeutic observations].
    Steinacher J
    Z Haut Geschlechtskr; 1972 Jul; 47(13):559-64. PubMed ID: 4569258
    [No Abstract]   [Full Text] [Related]  

  • 59. Rapid relief of signs/symptoms in chronic venous microangiopathy with pycnogenol: a prospective, controlled study.
    Cesarone MR; Belcaro G; Rohdewald P; Pellegrini L; Ledda A; Vinciguerra G; Ricci A; Gizzi G; Ippolito E; Fano F; Dugall M; Acerbi G; Cacchio M; Di Renzo A; Hosoi M; Stuard S; Corsi M
    Angiology; 2006; 57(5):569-76. PubMed ID: 17067979
    [TBL] [Abstract][Full Text] [Related]  

  • 60. [Some pharmacologic properties of a vasoactive combination].
    Tarayre JP; Lauressergues H
    Ann Pharm Fr; 1976; 34(9-10):375-82. PubMed ID: 1015760
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.